Applying Virtual Approaches to Dermatology Trials
Adoption of remote and virtual trial tools is helping to ensure the safety of dermatology patients during the pandemic. IQVIA Biotech shares how incorporating patient-centric approaches in future dermatology trials can increase patient access and engagement. Live: Tuesday, Jul. 21, 2020 at 11am EDT On demand available after airing until Jul. 21, 2021. Register free
Register free:
Event Overview:
Dermatology patients are eager to participate in trials from their homes during the COVID-19 pandemic. Sponsors and investigators managing dermatology clinical trials have quickly embraced remote and virtual tools to keep patients safe and keep trials moving forward.
Join our webinar and learn how to incorporate virtual approaches into the design and delivery of dermatology trials – to lower overall study risks and increase patient engagement.
Our experts will share:
- Lessons learned from ongoing dermatology trials due to COVID-19
- Innovative and flexible approaches that reduce patient and site burden, and improve the overall patient experience
- How to determine the right virtual/hybrid model for your clinical trial
Key Learnings
- Discover insights from the adoption of remote and virtual trial tools during the COVID-19 pandemic that are now leading to more patient-centric dermatology trials
- Recognize practical solutions to reduce the operational risks of dermatology trials while increasing patient safety
- Evaluate options such as telemedicine and connected devices to improve the clinical trial experience for dermatology patients, leading to improved recruitment and retention
Speakers: Sonja VanWye, RN, MSN, Director of Dermatology Strategy, IQVIA Biotech
Christopher Varner, Virtual Trials Project Manager, IQVIA
Jeff Bagshaw, Vice President, Global Business Development, IQVIA Biotech
Time and date: Tuesday, Jul. 21, 2020 at 11am EDT
On demand available after airing until Jul. 21, 2021.
Sponsor: IQVIA
Register free:
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- The Impact of ICH E6(R3) on Biospecimen Management
June 25th 2025
- The Top 5 Myths About eCOAs In 2025
March 25th 2025